Wish scientists could get over their love of a cool idea and focus on the disregard of ethics committees, the multiple violations of scientific practice that we’re supposed to be training folks in, and all this performed by a government employee funded by all of us.
If you really care about solving a problem and helping people, you don’t do gimmicks. You actually test your vaccine to ensure it is safe and effective. You take your responsibility seriously and work with your ethics committee. Especially if you are funded by the public.
Unethical in so many ways. There is a system for evaluating vaccines and this isn’t it.
I don’t know if anyone else notices or cares, but when I see a presentation in which the speaker uses obviously generated-AI images to illustrate their slides, it makes me immediately less confident in whatever other content they’re presenting.
We're hiring! Clinical Assistant Professor in Infectious Diseases. Great group of physicians and great community!
This only happens to you once
We’re trying to figure out the Bluey situation.
Wow, it's been a while since I've had to prepare a powerpoint in 4:3 aspect ratio!
A bizarre dogma has emerged among the anti-mRNA crowd that the only data we have on vaccines is from the original trial papers, rather than the HUGE volume of studies that came out subsequently...
Blood cultures - the next frontier in diagnostic stewardship? Anastasia Wasylyshyn from the Division contributing here.
journals.asm.org/doi/10.1128/...
New review on genomic epidemiology of C diff from Evan Snitkin in the Division.
www.sciencedirect.com/science/arti...
New data on RSV VE from the CDC sponsored IVY network. This sort of work could be in jeopardy given events of the last several weeks.
jamanetwork.com/journals/jam...
He’s not a therapy dog but I’m willing to bring my dog Wilmont to our noon conference 😂 @martenhawkins.bsky.social @lcahuaymemd.bsky.social
The federal government has decided to severely limit access to vaccines that have been shown to reduce illness, hospitalization, and death. Whereas we used to argue about whether government was forcing you to be vaccinated, now we government saying you can’t get vaccinated.
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study url: academic.oup.com/cid/article-...
open.substack.com/pub/clauswil... this is very true and highly under appreciated. Not just for a PhD but any high level accomplishment.
ID fellows: join IDSA Fellows Community of Practice & CPSolvers for a virtual Fellows Case Conference this Friday at 3PM ET! This session will include an interesting case presentation and small group discussion, featuring Daniel Minter, MD, and Varun Phadke, MD.
Register: https://bit.ly/47bJczm
New from Marisa Miceli in the Division!
Lack of Association Between Histoplasma Urine Antigen Values and Clinical Response in Persons Without HIV url: academic.oup.com/ofid/article...
Take 5 minutes and watch this. Destroying biomedical research is dangerous, quite literally. www.nytimes.com/2025/08/24/o...
Friday emails of funding opportunities from the NIH used to take a little time to digest. They've gotten a lot easier lately, today's especially.
California’s Valley Fever cases have jumped 1,200% in 25 years - from 1k to over 12.5k a year. Climate change, construction, agriculture - and perhaps increased familiarity and testing - are driving the surge.
www.sfgate.com/bayarea/arti...
I spy Jacco Boon!
one small consolation of being a 60+ year old investigator is the ability to submit to 𝘔𝘈𝘛𝘜𝘙𝘌 family journals — sure they’re low impact (for our knees) but they have an early bird special if you submit between 4:00 and 5:30 on weekdays
Novel oral polio vaccines, now in type 1 and type 3 “flavors”!
I share this in case you're very literal like me and wonder why people keep insisting it's because coronaviruses look like they have a crown, when they don't.
Apropos of nothing...
www.nature.com/articles/220...
Not to mention what it would do to society journals.
On IDSA’s & HIVMA’s Science Speaks blog: Learn about JID’s latest monthly roundup of papers relevant to clinicians, including advancements in defining post-COVID conditions, therapeutic success of adjunctive carbapenems for MRSA and more. buff.ly/Qvbuhxj
Nice work from Marisa Miceli in the Division.
